MAP4K4-IN-17
- CAS No.
- 1811510-58-3
- Chemical Name:
- MAP4K4-IN-17
- Synonyms
- Compound 17;MAP4K4-IN-3;MAP4K4-IN-17;MAP4K4-IN-3, 10 mM in DMSO;5-(6-Amino-5-(4-chlorophenyl)pyridin-3-yl)pyrimidin-2-amine;2-Pyrimidinamine, 5-[6-amino-5-(4-chlorophenyl)-3-pyridinyl]-;MAP4K,MAPK Kinase Kinase Kinase,Inhibitor,MAP4K4 IN 3,MAP4K4IN3,inhibit,MAP-4K4-IN-3
- CBNumber:
- CB75867412
- Molecular Formula:
- C15H12ClN5
- Molecular Weight:
- 297.74
- MDL Number:
- MFCD34469362
- MOL File:
- 1811510-58-3.mol
- MSDS File:
- SDS
- TDS File:
- TDS
MAP4K4-IN-17 price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-0088400 | MAP4K4-IN-3 99.77% | 1811510-58-3 | 5mg | $54 | 2026-06-04 | Buy |
| ChemScene | CS-0088400 | MAP4K4-IN-3 99.77% | 1811510-58-3 | 10mg | $97 | 2026-06-04 | Buy |
| ChemScene | CS-0088400 | MAP4K4-IN-3 99.77% | 1811510-58-3 | 25mg | $206 | 2026-06-04 | Buy |
| ChemScene | CS-0088400 | MAP4K4-IN-3 99.77% | 1811510-58-3 | 50mg | $325 | 2026-06-04 | Buy |
| ChemScene | CS-0088400 | MAP4K4-IN-3 99.77% | 1811510-58-3 | 100mg | $520 | 2026-06-04 | Buy |
MAP4K4-IN-17 Chemical Properties,Uses,Production
Uses
MAP4K4-IN-3 (Compound 17) is a potent and selective MAP4K4 inhibitor with an IC50 of 14.9 nM in kinase assay, an IC50 of 470 nM in cell assay. Antidiabetic agent[1].
in vivo
Oral dosing in telemetered rats for 5 days with MAP4K4-IN-3 (Compound 2; 25 mg/kg, b.i.d.) results in a number of adverse effects. Substantial weight losses (7%) and body temperature increases (0.4°C) relative to controls are observed over the course of the study. For cardiovascular end points, maximal heart rate increases of 25 bpm, relative to controls, are induced by treatment with MAP4K4-IN-3[2].
IC 50
MAP4K4: 14.9 nM (IC50)
References
[1] Ammirati M, et al. Discovery of an in Vivo Tool to Establish Proof-of-Concept for MAP4K4-Based AntidiabeticTreatment. ACS Med Chem Lett. 2015 Oct 6;6(11):1128-33. DOI:10.1021/acsmedchemlett.5b00215
[2] Dow RL, et al. 2-Aminopyridine-Based Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) Inhibitors: Assessment of Mechanism-Based Safety. J Med Chem. 2018 Apr 12;61(7):3114-3125. DOI:10.1021/acs.jmedchem.8b00152
MAP4K4-IN-17 Preparation Products And Raw materials
Raw materials
Preparation Products
MAP4K4-IN-17 Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| BOC Sciences | 1-631-485-4226; 16314854226 | info@bocsci.com | United States | 9920 | 65 |
| Dalian Meilun Biotech Co., Ltd. | 0411-62910999 13889544652 | sales@meilune.com | China | 4765 | 58 |
| Shanghai Lollane Biological Technology Co.,Ltd. | 021-52996696,15000506266 15000506266 | China | 4861 | 55 | |
| Shanghai YuanYe Biotechnology Co., Ltd. | 15026964105 | 2881489226@qq.com | China | 89667 | 60 |
| Shanghai SuperLan Chemcial Technique Centre | 0-2022843681 15618226720 | chaolaichem@foxmail.com | China | 10000 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 | sales@hzclap.com | CHINA | 6288 | 58 |
| Zhejiang Huida Biotech Co., LTD | 0571-89903022 18679456698 | zilong@hizyme.com | China | 8001 | 58 |
| Jinan Jiuli Biotechnology Co. , Ltd. | 15865264761 | 486064515@qq.com | China | 4960 | 58 |
| Bide Pharmatech Ltd. | 400-1647117 13681763483 | product02@bidepharm.com | China | 59929 | 58 |
View Lastest Price from MAP4K4-IN-17 manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-07-27 | MAP4K4-IN-3
1811510-58-3
|
$39.00-155.00 | 99.50% | 10g | TargetMol Chemicals Inc. | ||
![]() |
2026-07-27 | MAP4K4-IN-3
1811510-58-3
|
$39.00-155.00 | 99.50% | 10g | TargetMol Chemicals Inc. |
-

- MAP4K4-IN-3
1811510-58-3
- $39.00-155.00
- 99.50%
- TargetMol Chemicals Inc.
-

- MAP4K4-IN-3
1811510-58-3
- $39.00-155.00
- 99.50%
- TargetMol Chemicals Inc.




